Emphasis on Product Type (CRISPR Products and CRISPR Services); Application (Agricultural, Biomedical (Gene Therapy, Drug Discovery, And Diagnostics), Industrial, and Others); End-User (Academic Institutes & Research Centres, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical & Biopharmaceutical Companies); and Region/Country
The global CRISPR Gene Editing Market is expected to grow at a significant rate of around 5% during the forecast period. CRISPR gene editing is a scientific method that enables geneticists and medical researchers to modify, add, or delete specific DNA sequences to alter portions of the genome. It is currently the most straightforward, adaptable, and precise method of genetic modification. CRISPR has a lot of potential as a tool for treating genetic diseases like cancer, high cholesterol, and hepatitis B. For instance, according to the World Health Organization, around 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections occurring every year.
The CRISPR gene editing market is a rapidly growing and highly competitive market, driven by the increasing demand for new and effective treatments for various diseases and conditions, as well as the growing interest in precision medicine and personalized treatments. With advancements in technology and the increasing number of companies entering the market, the market is expected to continue growing in the coming years. For instance, in 2020, zon Discovery Group launched the Edit-R CRISPRa Portfolio. The Edit-R CRISPRa Portfolio is a collection of plasmids that use CRISPR activation (CRISPRa) technology to turn on the expression of specific genes in mammalian cells. The Edit-R CRISPRa Portfolio provides researchers with a powerful tool for studying gene function and developing new therapies for genetic diseases.
CRISPR Therapeutics; Thermo Fisher Scientific Inc.; Synthego; System Biosciences, LLC; ToolGen, Inc.; Agilent Technologies, Inc.; Merck KGaA; Applied StemCell; GeneCopoeia, Inc.; Cellecta, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst applications, the agricultural category is anticipated to register the fastest growth rate during the forecast period.”
On the basis of application, the market is categorized into agricultural, biomedical (gene therapy, drug discovery, and diagnostics), industrial, and others. Among these, the agricultural category is anticipated to register the fastest growth rate during the forecast period. This is mainly due to the consumption of nutritional food has risen globally because of improvements in agricultural productivity brought on by the adoption of advanced breeding technologies. For instance, researchers at Cold Spring Harbor Laboratory used CRISPR/Cas9 technology in June 2019 to create mutations in the tomato flowering suppressor, which led to quick flowering, more compact development, and ultimately an early harvest.
“Amongst end-user, academic institutes and research centers category to witness fastest CAGR during the forecast period.”
Based on end-user, the market is segmented into academic institutes & research centers, biotechnology companies, contract research organizations (CROs), and pharmaceutical & biopharmaceutical companies. The academic institutes and research centers category witness the fastest CAGR during the forecast period owing to their fundamental research, innovation, training & education, and collaborations with industry partners. These activities are crucial for the continued growth and success of the CRISPR gene editing market.
“APAC is anticipated to witness the fastest growth of the market”
For a better understanding of the market adoption of the CRISPR gene editing industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to witness the fastest growth in the market. This is mainly due to the increasing investments in gene editing research, the rising prevalence of genetic disorders, and the adoption of CRISPR technology in agriculture & animal breeding in the region. Also, the increasing government investment in R&D and patents assigned for these technologies to develop novel treatments is driving market expansion in developing countries. For instance, in March 2021, a CRISPR-Cas9 patent was given to the Japanese biotech firm Setsuro Tech by the Dublin-based ERS Genomics. With the help of these advanced technologies, the company is developing cell & animal models.
Reasons to buy this report:
Customization Options:
The global CRISPR gene editing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Impact Of Covid-19 On The Crispr Gene Editing Market
6. Crispr Gene Editing Market Revenue, 2020-2028f
7. Market Insights By Product Type
8. Market Insights By Application
9. Market Insights By End-user
10. Market Insights By Region
11. Crispr Gene Editing Market Dynamics
12. Crispr Gene Editing Market Opportunities
13. Crispr Gene Editing Market Trends
14. Demand And Supply-side Analysis
15. Value Chain Analysis
16. Pricing Analysis
17. Strategic Insights
18. Competitive Scenario
19. Company Profiled
20. Disclaimer
Research Methodology for the CRISPR Gene Editing Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global CRISPR gene editing market were the three major steps undertaken to create and analyze the adoption of CRISPR gene editing in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global CRISPR gene editing market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the CRISPR gene editing market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the CRISPR gene editing market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product type, application, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the CRISPR Gene Editing Market. Further, we conducted factor analysis using dependent and independent variables such as various product type, application, and end-users of CRISPR gene editing. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the CRISPR gene editing market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global CRISPR gene editing market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global CRISPR gene editing market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product type, application, and end-user in the global CRISPR gene editing market.
The main objective of the Global CRISPR Gene Editing Market Study
The current & future market trends of the global CRISPR gene editing market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
